SlideShare une entreprise Scribd logo
1  sur  9
8.3 TESTING A
PROPORTION
   P-VALUES
Testing a Proportion

• To test a proportion, we will use a similar process to
  those for testing the mean (8.1 & 8.2)
  • The main difference is that we are working with a
    distribution of proportions
Testing a Proportion

•
Note: p is a
probability,
therefore k must
be between 0
and 1
•
A team of eye surgeons has developed a new
technique for a risky eye operation to restore the
sight of people blinded from a certain disease. Under
the old method, it is known that only 30% of the
patients who undergo this operation recover their
eyesight. Suppose that surgeons in various hospitals
have performed a total of 225 operations using the
new method and that 88 have been successful (i.e.,
the patients fully recovered their sight). Can we justify
the claim that the new method is better than the old
one? (Use a 1% level of significance.)
•
•
•

Contenu connexe

En vedette

8.3 critical region
8.3 critical region8.3 critical region
8.3 critical regionleblance
 
Parent night contact&survey
Parent night contact&surveyParent night contact&survey
Parent night contact&surveyleblance
 
7.3 daqy 2
7.3 daqy 27.3 daqy 2
7.3 daqy 2leblance
 
What So Funny About Proportion Testv3
What So Funny About Proportion Testv3What So Funny About Proportion Testv3
What So Funny About Proportion Testv3ChrisConnors
 

En vedette (8)

1.6
1.61.6
1.6
 
8.3 critical region
8.3 critical region8.3 critical region
8.3 critical region
 
Parent night contact&survey
Parent night contact&surveyParent night contact&survey
Parent night contact&survey
 
7.1
7.17.1
7.1
 
7.3 daqy 2
7.3 daqy 27.3 daqy 2
7.3 daqy 2
 
What So Funny About Proportion Testv3
What So Funny About Proportion Testv3What So Funny About Proportion Testv3
What So Funny About Proportion Testv3
 
7.3
7.37.3
7.3
 
Slideshare ppt
Slideshare pptSlideshare ppt
Slideshare ppt
 

Similaire à 8.3

Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxChemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxHakimuNsubuga2
 
BBI - ECO: Digital Health in the North
BBI - ECO: Digital Health in the NorthBBI - ECO: Digital Health in the North
BBI - ECO: Digital Health in the NorthInnovation Agency
 
Qc failure lecture - Dr tamer soliman
Qc failure lecture - Dr tamer solimanQc failure lecture - Dr tamer soliman
Qc failure lecture - Dr tamer solimanTamer Soliman
 
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfBALASUNDARESAN M
 
What do clinicians need to know about lab tests?
What do clinicians need to know about lab tests?What do clinicians need to know about lab tests?
What do clinicians need to know about lab tests?Ola Elgaddar
 
Ian Blunt: PARR-30: a predictive model for readmission within 30 days
Ian Blunt: PARR-30: a predictive model for readmission within 30 daysIan Blunt: PARR-30: a predictive model for readmission within 30 days
Ian Blunt: PARR-30: a predictive model for readmission within 30 daysNuffield Trust
 
How to Validate a New Test.pdf
How to Validate a New Test.pdfHow to Validate a New Test.pdf
How to Validate a New Test.pdfHaythamHagrass
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility AnalysisLanceCatedral
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 Randox
 
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...Srihari Cattamanchi
 
2. Quality Control Notes
2. Quality Control Notes2. Quality Control Notes
2. Quality Control NotesLeah Molai
 
Hysterectomy Data Analysis & Surgery Cost Prediction
Hysterectomy Data Analysis & Surgery Cost PredictionHysterectomy Data Analysis & Surgery Cost Prediction
Hysterectomy Data Analysis & Surgery Cost PredictionChirag Ghelani
 
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...Office of Health Economics
 
MDC Connects: Principles and Modelling of PK and PD Relationships
MDC Connects: Principles and Modelling of PK and PD RelationshipsMDC Connects: Principles and Modelling of PK and PD Relationships
MDC Connects: Principles and Modelling of PK and PD RelationshipsMedicines Discovery Catapult
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocolsMario Sanchez
 
Appendicectomy national meeting
Appendicectomy national meetingAppendicectomy national meeting
Appendicectomy national meetinganeelbhangu
 
Sample determinants and size
Sample determinants and sizeSample determinants and size
Sample determinants and sizeTarek Tawfik Amin
 
is laser treatment is really a good decision for a women????think...Impact of...
is laser treatment is really a good decision for a women????think...Impact of...is laser treatment is really a good decision for a women????think...Impact of...
is laser treatment is really a good decision for a women????think...Impact of...ShitalSavaliya1
 
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy Planning
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy PlanningDvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy Planning
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy PlanningAz.Ospedaliero-Universitaria di Modena
 
Gaudreault et al-2015-anesthesia_&_analgesia
Gaudreault et al-2015-anesthesia_&_analgesiaGaudreault et al-2015-anesthesia_&_analgesia
Gaudreault et al-2015-anesthesia_&_analgesiasamirsharshar
 

Similaire à 8.3 (20)

Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptxChemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
Chemometrics-ANALYTICAL DATA SIGNIFICANCE TESTS.pptx
 
BBI - ECO: Digital Health in the North
BBI - ECO: Digital Health in the NorthBBI - ECO: Digital Health in the North
BBI - ECO: Digital Health in the North
 
Qc failure lecture - Dr tamer soliman
Qc failure lecture - Dr tamer solimanQc failure lecture - Dr tamer soliman
Qc failure lecture - Dr tamer soliman
 
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdfANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
ANALYTICAL METHOD VALIDATION (PHARMACEUTICAL INDUSTRY).pdf
 
What do clinicians need to know about lab tests?
What do clinicians need to know about lab tests?What do clinicians need to know about lab tests?
What do clinicians need to know about lab tests?
 
Ian Blunt: PARR-30: a predictive model for readmission within 30 days
Ian Blunt: PARR-30: a predictive model for readmission within 30 daysIan Blunt: PARR-30: a predictive model for readmission within 30 days
Ian Blunt: PARR-30: a predictive model for readmission within 30 days
 
How to Validate a New Test.pdf
How to Validate a New Test.pdfHow to Validate a New Test.pdf
How to Validate a New Test.pdf
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
 
EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649 EQA: An Essential Tool for Laboratory Quality - Africa LT649
EQA: An Essential Tool for Laboratory Quality - Africa LT649
 
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...
A PROSPECTIVE EVALUATION OF “KETOFOL”, KETAMINE & PROPOFOL COMBINATION FOR PR...
 
2. Quality Control Notes
2. Quality Control Notes2. Quality Control Notes
2. Quality Control Notes
 
Hysterectomy Data Analysis & Surgery Cost Prediction
Hysterectomy Data Analysis & Surgery Cost PredictionHysterectomy Data Analysis & Surgery Cost Prediction
Hysterectomy Data Analysis & Surgery Cost Prediction
 
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
Comparing Cancer-Specific Preference-Based Outcome Measures: The Same but Dif...
 
MDC Connects: Principles and Modelling of PK and PD Relationships
MDC Connects: Principles and Modelling of PK and PD RelationshipsMDC Connects: Principles and Modelling of PK and PD Relationships
MDC Connects: Principles and Modelling of PK and PD Relationships
 
Impactof en feeding protocols
Impactof en feeding protocolsImpactof en feeding protocols
Impactof en feeding protocols
 
Appendicectomy national meeting
Appendicectomy national meetingAppendicectomy national meeting
Appendicectomy national meeting
 
Sample determinants and size
Sample determinants and sizeSample determinants and size
Sample determinants and size
 
is laser treatment is really a good decision for a women????think...Impact of...
is laser treatment is really a good decision for a women????think...Impact of...is laser treatment is really a good decision for a women????think...Impact of...
is laser treatment is really a good decision for a women????think...Impact of...
 
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy Planning
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy PlanningDvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy Planning
Dvh Pitfal In Volume Evaluetion For Spinal Cord Using Tomotherapy Planning
 
Gaudreault et al-2015-anesthesia_&_analgesia
Gaudreault et al-2015-anesthesia_&_analgesiaGaudreault et al-2015-anesthesia_&_analgesia
Gaudreault et al-2015-anesthesia_&_analgesia
 

Plus de leblance

10.3 part 1
10.3 part 110.3 part 1
10.3 part 1leblance
 
10.1 part2
10.1 part210.1 part2
10.1 part2leblance
 
10.1 part 1
10.1 part 110.1 part 1
10.1 part 1leblance
 
Ch 9 practice exam
Ch 9 practice examCh 9 practice exam
Ch 9 practice examleblance
 
5.4 synthetic division
5.4 synthetic division5.4 synthetic division
5.4 synthetic divisionleblance
 
5.4 long division
5.4 long division5.4 long division
5.4 long divisionleblance
 
9.3 Part 1
9.3 Part 19.3 Part 1
9.3 Part 1leblance
 
9.1 9.2 9.3 using the graph calc
9.1 9.2 9.3 using the graph calc9.1 9.2 9.3 using the graph calc
9.1 9.2 9.3 using the graph calcleblance
 
5.1 part 2
5.1 part 25.1 part 2
5.1 part 2leblance
 
9.2 lin reg coeff of det
9.2 lin reg coeff of det9.2 lin reg coeff of det
9.2 lin reg coeff of detleblance
 
Ch 8 review answers
Ch 8 review answersCh 8 review answers
Ch 8 review answersleblance
 
8.3 critical region
8.3 critical region8.3 critical region
8.3 critical regionleblance
 
8.4 guided notes
8.4 guided notes8.4 guided notes
8.4 guided notesleblance
 

Plus de leblance (20)

7.2
7.27.2
7.2
 
10.3 part 1
10.3 part 110.3 part 1
10.3 part 1
 
10.2
10.210.2
10.2
 
10.1 part2
10.1 part210.1 part2
10.1 part2
 
10.1 part 1
10.1 part 110.1 part 1
10.1 part 1
 
Ch 9 practice exam
Ch 9 practice examCh 9 practice exam
Ch 9 practice exam
 
5.4 synthetic division
5.4 synthetic division5.4 synthetic division
5.4 synthetic division
 
5.4 long division
5.4 long division5.4 long division
5.4 long division
 
5.3
5.35.3
5.3
 
9.3 Part 1
9.3 Part 19.3 Part 1
9.3 Part 1
 
9.1 9.2 9.3 using the graph calc
9.1 9.2 9.3 using the graph calc9.1 9.2 9.3 using the graph calc
9.1 9.2 9.3 using the graph calc
 
5.2
5.25.2
5.2
 
5.1 part 2
5.1 part 25.1 part 2
5.1 part 2
 
5.1[1]
5.1[1]5.1[1]
5.1[1]
 
9.1
9.19.1
9.1
 
9.2 lin reg coeff of det
9.2 lin reg coeff of det9.2 lin reg coeff of det
9.2 lin reg coeff of det
 
Ch 8 review answers
Ch 8 review answersCh 8 review answers
Ch 8 review answers
 
8.4
8.48.4
8.4
 
8.3 critical region
8.3 critical region8.3 critical region
8.3 critical region
 
8.4 guided notes
8.4 guided notes8.4 guided notes
8.4 guided notes
 

8.3

  • 2. Testing a Proportion • To test a proportion, we will use a similar process to those for testing the mean (8.1 & 8.2) • The main difference is that we are working with a distribution of proportions
  • 4. Note: p is a probability, therefore k must be between 0 and 1
  • 5.
  • 6. A team of eye surgeons has developed a new technique for a risky eye operation to restore the sight of people blinded from a certain disease. Under the old method, it is known that only 30% of the patients who undergo this operation recover their eyesight. Suppose that surgeons in various hospitals have performed a total of 225 operations using the new method and that 88 have been successful (i.e., the patients fully recovered their sight). Can we justify the claim that the new method is better than the old one? (Use a 1% level of significance.)
  • 7.
  • 8.
  • 9.